West Pharmaceutical Services
West Pharmaceutical Services is a global leader in the design and manufacture of high-quality containment and delivery systems for injectable medicines. The company provides integrated solutions that ensure the safe and efficient administration of drugs, ranging from primary packaging components to sophisticated drug delivery devices and contract manufacturing services.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Proprietary Products
primaryThis segment focuses on the design, manufacture, and sale of proprietary packaging and delivery systems. It provides high-value components and systems that are often integrated into customers' drug products to ensure stability and delivery performance.
NovaPure, Westar, FluroTec, Daikyo Crystal Zenith, SmartDose, SelfDose
Biologic companies, Pharmaceutical companies, Generic drug manufacturers
Contract-Manufactured Products
majorThis segment serves as a fully integrated solution provider for medical device, diagnostic, and consumer product companies. It offers design, engineering, and manufacturing services for complex plastic components and assembled devices.
Injection-molded components, Multi-component medical devices, Diagnostic kit components
Diagnostic companies, Medical device manufacturers, Consumer healthcare companies
Segment Financials
Proprietary Products — Net Sales
View metricProprietary Products — R&D
View metricStandard Packaging — Concentration risk, percentage
View metricContract-Manufactured Products — Foreign currency translation
View metricBusiness Overview
Competitive Position
A dominant global player in the injectable drug containment market, characterized by high switching costs and rigorous regulatory quality standards.
Geographies
North America, Europe, Asia-Pacific, South America
Customer Segments
Biopharmaceutical companies, Generic drug manufacturers, Medical device OEMs
Upstream Dependencies
Elastomeric raw material suppliers, Specialty polymer producers, Aluminum and plastic resin suppliers
Downstream Customers
Biotechnology firms, Global pharmaceutical corporations, Contract Development and Manufacturing Organizations (CDMOs)
Competitors & Partners
Competitors
Partners
Daikyo Seiko, Ltd.
Long-term strategic partner for the distribution and manufacture of FluroTec and Crystal Zenith products
Subsidiaries
Medimop Medical Projects Ltd.
Developer of reconstitution and transfer systems
The Tech Group
Contract manufacturing business unit for medical devices
West Pharmaceutical Services FAQ
Common questions about West Pharmaceutical Services
West Pharmaceutical Services is a global leader in the design and manufacture of high-quality containment and delivery systems for injectable medicines. The company provides integrated solutions that ensure the safe and efficient administration of drugs, ranging from primary packaging components to sophisticated drug delivery devices and contract manufacturing services.
West Pharmaceutical Services (WST) has a market capitalization of $21.5B and trades on NYSE.
West Pharmaceutical Services generated $3.2B in trailing twelve-month revenue with net income of $542.7M, representing a net margin of 16.9%. Gross margin stands at 36.3%, with free cash flow of $458.0M. These figures are based on the Q1 2026 filing.
West Pharmaceutical Services's key competitors include Becton, Dickinson and Company, AptarGroup, Inc., Stevanato Group, and others. These companies compete in similar markets and product categories.
West Pharmaceutical Services has approximately 10,600 employees.